Literature DB >> 22458899

Selected common diagnostic problems in urologic pathology: perspectives from a large consult service in genitourinary pathology.

Fadi Brimo1, Jonathan I Epstein.   

Abstract

CONTEXT: Several common differential diagnoses are encountered in urologic pathology, frequently causing patient referrals for a second opinion.
OBJECTIVES: To review 3 common differential diagnoses encountered in a large consultation service in genitourinary pathology, including partial atrophy versus prostatic acinar adenocarcinoma, oncocytoma versus chromophobe renal cell carcinoma, and urothelial carcinoma in situ versus normal urothelium and reactive atypia. We will discuss the detailed, morphologically distinctive features and the usefulness of immunohistochemistry. DATA SOURCES: Personal experience and review of the current literature.
CONCLUSIONS: Careful morphologic assessment and awareness of diagnostic pitfalls are fundamental in reaching a definitive diagnosis in most cases. Immunohistochemistry is useful but should be used only in conjunction with the morphologic impression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22458899     DOI: 10.5858/arpa.2011-0187-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  4 in total

1.  Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication.

Authors:  Ana Sílvia Pires-Luís; Márcia Vieira-Coimbra; Filipa Quintela Vieira; Pedro Costa-Pinheiro; Rui Silva-Santos; Paula C Dias; Luís Antunes; Francisco Lobo; Jorge Oliveira; Céline S Gonçalves; Bruno M Costa; Rui Henrique; Carmen Jerónimo
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

2.  Nuclear size measurement for distinguishing urothelial carcinomas from reactive urothelium on tissue sections.

Authors:  Kate Poropatich; Jason C Yang; Rajen Goyal; Vamsi Parini; Ximing J Yang
Journal:  Diagn Pathol       Date:  2016-06-30       Impact factor: 2.644

Review 3.  Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project.

Authors:  P J Zondervan; P G K Wagstaff; M M Desai; D M de Bruin; A F Fraga; B A Hadaschik; J Köllermann; U B Liehr; S A Pahernik; H P Schlemmer; J J Wendler; F Algaba; J J M C H de la Rosette; M P Laguna Pes
Journal:  World J Urol       Date:  2016-04-22       Impact factor: 4.226

4.  TGF-β1 expression in chromophobe renal cell carcinoma and renal oncocytoma.

Authors:  A Demirović; S Cesarec; Z Marušić; D Tomas; M Milošević; T Hudolin; B Krušlin
Journal:  Eur J Histochem       Date:  2014-01-31       Impact factor: 3.188

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.